Pig-to-nonhuman primate organ xenotransplantation

Purpose of reviewThe availability of α1,3-galactosyltransferase gene-knockout pigs in which the major target for primate anti-pig antibodies has been deleted is considered a major step toward clinical xenotransplantation. A review of progress in pig-to-nonhuman primate transplantation is therefore timely. Recent findingsSeveral groups have continued their studies using pigs transgenic for one or more human complement regulatory proteins, with graft survival reaching more than 3 months in some cases. Significant complications have resulted from the intensity of immunosuppression required to achieve these results, however. The use of organs from α1,3-galactosyltransferase gene-knockout pigs has eliminated hyperacute rejection in baboons. Heterotopic heart α1,3-galactosyltransferase gene-knockout xenografts maintained with chronic immunosuppression survived up to 6 months, with graft failure associated with thrombotic microangiopathy. Life-supporting renal xenografts maintained with a tolerance-inducing regimen survived over 80 days, with the longest survivors dying with functioning grafts. SummaryThe availability of α1,3-galactosyltransferase gene-knockout donor pigs has eliminated the need for inhibition of antibodies to α1,3 galactose (Gal) or complement to prevent hyperacute rejection. It has also had a positive impact on the survival of heterotopic xenogeneic hearts transplanted under chronic immunosuppression and on the survival of orthotopic kidneys transplanted with donor thymus tissue in an attempt to induce tolerance. Problems remain to be resolved, including the effects of the variable presence of antibodies to non-Gal antigens, the high incidence of thrombotic microangiopathy in heart xenotransplants, and loss of animals to other causes in the recipients of orthotopic renal transplants. Nevertheless, the results with α1,3-galactosyltransferase gene-knockout donors are encouraging for the future of this field.

[1]  H. Tazelaar,et al.  Prevention, detection, and management of early bacterial and fungal infections in a preclinical cardiac xenotransplantation model that achieves prolonged survival , 2005, Xenotransplantation.

[2]  B. Reichart,et al.  Administration of GAS914 in an orthotopic pig‐to‐baboon heart transplantation model , 2005, Xenotransplantation.

[3]  G. Berry,et al.  Improved assessment of graft function by echocardiography in cynomolgus monkey recipients of hDAF-transgenic pig cardiac xenografts. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  U. Christians,et al.  The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF‐transgenic pig‐to‐primate life‐supporting kidney xenografts , 2005, Xenotransplantation.

[5]  N. Mueller,et al.  Early weaning of piglets fails to exclude porcine lymphotropic herpesvirus , 2005, Xenotransplantation.

[6]  D. Sachs,et al.  Marked prolongation of porcine renal xenograft survival in baboons through the use of α1,3-galactosyltransferase gene-knockout donors and the cotransplantation of vascularized thymic tissue , 2005, Nature Medicine.

[7]  N. Mueller,et al.  Heart transplantation in baboons using α1,3-galactosyltransferase gene-knockout pigs as donors: initial experience , 2005, Nature Medicine.

[8]  H. Tazelaar,et al.  Cardiac Xenotransplantation: Progress Toward the Clinic , 2004, Transplantation.

[9]  R. Lechler,et al.  Complete Inhibition of Acute Humoral Rejection Using Regulated Expression of Membrane‐tethered Anticoagulants on Xenograft Endothelium , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[10]  N. Mueller,et al.  Reduction of Consumptive Coagulopathy Using Porcine Cytomegalovirus-Free Cardiac Porcine Grafts in Pig-to-Primate Xenotransplantation , 2004, Transplantation.

[11]  G. Berry,et al.  Hyperacute rejection of hDAF‐transgenic pig organ xenografts in cynomolgus monkeys: influence of pre‐existing anti‐pig antibodies and prevention by the αGAL glycoconjugate GAS914 , 2004, Xenotransplantation.

[12]  R. Morris,et al.  Anti‐non‐Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF‐transgenic porcine hearts in cynomolgus monkeys , 2004, Xenotransplantation.

[13]  H. Schuurman,et al.  Transgenic expression in pig hearts of both human decay-accelerating factor and human membrane cofactor protein does not provide an additional benefit to that of human decay-accelerating factor alone in pig-to-baboon xenotransplantation. , 2004, Transplantation.

[14]  R. Mañez,et al.  Failure to deplete anti‐Galα1‐3Gal antibodies after pig‐to‐baboon organ xenotransplantation by immunoaffinity columns containing multiple Galα1‐3Gal oligosaccharides , 2004, Xenotransplantation.

[15]  K. Kuwaki,et al.  Thrombotic microangiopathy and graft arteriopathy in pig hearts following transplantation into baboons , 2004, Xenotransplantation.

[16]  H. Tazelaar,et al.  Effective antiplatelet therapy does not prolong transgenic pig to baboon cardiac xenograft survival , 2004, Xenotransplantation.

[17]  H. Schuurman,et al.  Does exposure to swine leukocyte antigens after pig‐to‐nonhuman primate xenotransplantation provoke antibodies that cross‐react with human leukocyte antigens? , 2004, Xenotransplantation.

[18]  R. Kurth,et al.  Inhibition of porcine endogenous retroviruses by RNA interference: increasing the safety of xenotransplantation. , 2004, Virology.

[19]  D. Sachs,et al.  &agr;1,3-Galactosyltransferase Gene-Knockout Miniature Swine Produce Natural Cytotoxic Anti-Gal Antibodies , 2004, Transplantation.

[20]  H. Yang,et al.  Xenotransplantation of human decay accelerating factor transgenic porcine kidney to non-human primates: 4 years experience at a Canadian center. , 2004, Transplantation proceedings.

[21]  S. Robson,et al.  ACUTE VASCULAR REJECTION OF XENOGRAFTS: ROLES OF NATURAL AND ELICITED XENOREACTIVE ANTIBODIES IN ACTIVATION OF VASCULAR ENDOTHELIAL CELLS AND INDUCTION OF PROCOAGULANT ACTIVITY , 2004, Transplantation.

[22]  B. Weill,et al.  Characterization of human CD55 and CD59 transgenic pigs and kidney xenotransplantation in the pig-to-baboon combination. , 2004, Transplantation.

[23]  D. B. Carter,et al.  Production of (cid:1) -1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations , 2022 .

[24]  N. Mueller,et al.  Activation of porcine cytomegalovirus, but not porcine lymphotropic herpesvirus, in pig-to-baboon xenotransplantation. , 2004, The Journal of infectious diseases.

[25]  D. Sachs,et al.  Vascularized thymic lobe transplantation in miniature swine: thymopoiesis and tolerance induction across fully MHC-mismatched barriers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Tesson,et al.  The study of mitoxantrone as a potential immunosuppressor in transgenic pig renal xenotransplantation in baboons: comparison with cyclophosphamide , 2004, Xenotransplantation.

[27]  B. Loveland,et al.  Characterization of a CD46 transgenic pig and protection of transgenic kidneys against hyperacute rejection in non‐immunosuppressed baboons , 2004, Xenotransplantation.

[28]  N. Mueller,et al.  Suppression of Natural and Elicited Antibodies in Pig‐to‐Baboon Heart Transplantation Using a Human Anti‐Human CD154 mAb‐Based Regimen , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  K. Kuwaki,et al.  Absence of humoral and cellular alloreactivity in baboons sensitized to pig antigens , 2004, Xenotransplantation.

[30]  D. Sachs,et al.  Thymic transplantation in miniature swine: III. induction of tolerance by transplantation of composite thymokidneys across fully major histocompatibility complex-mismatched barriers , 2003, Transplantation.

[31]  R. Colvin,et al.  Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model: I. evidence for pig-specific T-cell unresponsiveness1 , 2003, Transplantation.

[32]  D. Sachs,et al.  Histocompatible miniature swine: an inbred large-animal model1 , 2003, Transplantation.

[33]  T. Starzl,et al.  Production of alpha 1,3-galactosyltransferase-deficient pigs. , 2003, Science.

[34]  S. H. A. Chen,et al.  Production of α1,3-Galactosyltransferase-Deficient Pigs , 2002, Science.

[35]  D. Sachs,et al.  Vascularized thymic lobe transplantation in miniature swine: I. Vascularized thymic lobe allografts support thymopoiesis1 , 2002, Transplantation.

[36]  R. Colvin,et al.  Thymic Transplantation in Miniature Swine. II. Induction of Tolerance by Transplantation of Composite Thymokidneys to Thymectomized Recipients1 , 2000, The Journal of Immunology.

[37]  R. Colvin,et al.  Thymic transplantation in miniature swine. I. Development and function of the "thymokidney". , 1999, Transplantation.

[38]  D. Sachs,et al.  Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. , 1995, Journal of immunology.

[39]  J. Pober,et al.  Porcine aortic endothelial cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. , 1994, Immunity.